SCHEMBL4592239

SCHEMBL4592239

CC(C)(O)C(C)(C)OB(O)c1cccc(Cl)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 1/20 0.35
HSD11B1 P28845 1/20 0.34
ENPP2 Q13822 2/20 0.33
TSHR P16473 1/20 0.33
SLC6A2 P23975 2/20 0.31
CHRNA1 P02708 1/20 0.31
CHRNG P07510 1/20 0.31
ITGA5 P08648 1/20 0.31
CHRNB1 P11230 1/20 0.31
CHRNB2 P17787 1/20 0.31
CHRNB4 P30926 1/20 0.31
SLC6A4 P31645 1/20 0.31
CHRNA3 P32297 1/20 0.31
CYP2C19 P33261 1/20 0.31
HRH1 P35367 1/20 0.31
CHRNA7 P36544 1/20 0.31
OPRK1 P41145 1/20 0.31
CHRNA4 P43681 1/20 0.31
SLC6A3 Q01959 1/20 0.31
CHRND Q07001 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16223353 0.82 ACHE (0.35) ENPP2ALDH1A1CYP26B1
SCHEMBL517851 0.82 ENPP2 (0.48) ENPP2TSHRCHRNB2CHRNB4CHRNA3
SCHEMBL16010449 0.81 MGLL (0.39) ENPP2CYP26B1
SCHEMBL1032711 0.81 ALDH1A1 (0.50) ENPP2TSHRALDH1A1CYP26B1F10
SCHEMBL3518819 0.81 CYP26B1 (0.46) ENPP2CYP2C19ALDH1A1CYP26B1
SCHEMBL117688 0.80 ENPP2 (0.43) ENPP2TSHRCYP2C19ORAI1ORAI2
SCHEMBL14830420 0.79 MGLL (0.51) ENPP2ORAI1ORAI2ORAI3TRPV6
SCHEMBL2300859 0.79 ENPP2 (0.57) ENPP2TSHRRELAALDH1A1HTR3E
SCHEMBL119711 0.79 TRPV6 (0.39) ENPP2CYP2C19ORAI1ORAI2ORAI3
SCHEMBL22684756 0.78 ALDH1A1 (0.40) ENPP2TSHRALDH1A1SMN1; SMN2F10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107849035-A Phenyl heterocyclic derivative and application thereof in medicine 四川海思科制药有限公司 2018-03-27 CN disclosed
CN-105523996-A Amide-type derivative and its preparation method and use in medicine JIANGSU HENGRUI MEDICINE CO 2016-04-27 CN disclosed
WO-2013157792-A1 BICYCLIC HETEROARYL DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME HANMI PHARM. CO., LTD. (KR) 2013-10-24 WO disclosed
US-7429605-B2 Phenylpyridine derivatives HOFFMANN-LA ROCHE INC. (US) 2008-09-30 US disclosed
CN-101213186-A Phenylpyridine derivatives, their manufacture and use as pharmaceutical agents HOFFMANN LA ROCHE (CH) 2008-07-02 CN disclosed
EP-1912969-A1 PHENYLPYRIDINE DERIVATIVES, THEIR MANUFACTURE AND USE AS PHARMACEUTICAL AGENTS F.HOFFMANN-LA ROCHE AG (CH) 2008-04-23 EP disclosed
WO-2007017169-A1 PHENYLPYRIDINE DERIVATIVES, THEIR MANUFACTURE AND USE AS PHARMACEUTICAL AGENTS F. HOFFMANN-LA ROCHE AG (CH) 2007-02-15 WO disclosed
US-20070032530-A1 Phenylpyridine derivatives HOFFMANN-LA ROCHE INC. 2007-02-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070032530-A1 Phenylpyridine derivatives CYP3A5, QDPR, DPYD PGR 555/4885HSD11B1 1978/4885ENPP2 3831/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.